| Similar Articles |
|---|
 |
The Motley Fool
February 9, 2004
Paul Elliott |
Small Cap Floating on Air CNS, maker of Breathe Right nasal strips, is a stock I love. The attraction is financial. And CNS's financials are a thing of beauty, starting with a pile of cash -- $46.87 million -- and not a penny of debt.   |
The Motley Fool
January 26, 2006
Nathan Parmelee |
CNS Is All Stuffed Up The company that gave us Breathe Right nasal strips missed analyst estimates and the stock gets crushed. |
The Motley Fool
January 21, 2005
W.D. Crotty |
CNS Strips for Profits Nasal strip sales soar, and so do the company's third-quarter profits. |
The Motley Fool
August 4, 2005
Nathan Parmelee |
Still a Green Monster Spectacular earnings growth and a strong margin make for a very strong quarter at consumer products company CNS. |
The Motley Fool
October 22, 2004
W.D. Crotty |
CNS's Whiff of Fresh Air The company's Breathe Right franchise is a real money machine. Net income of $0.24 a share beat analyst estimates by $0.05 and the top end of the company's guidance. |
The Motley Fool
April 29, 2005
W.D. Crotty |
CNS Has a Nose for Cash The company that gave us Breathe Rights continues to build a large cash hoard. Investors, take note. |
The Motley Fool
April 30, 2004
Rick Aristotle Munarriz |
CNS "Nose" Best The company that created the Breathe Right nasal strips is apparently doing a few more things right than just breathing. Its stock closed yesterday at just 16 times its median profit target. |
The Motley Fool
November 29, 2004
Rich Duprey |
A Patented Challenge to CNS The Patent and Trademark Office is reconsidering two patents of the nasal strips maker. Investors took notice and slapped the company down 8%, which ought to present an opportunity to pick up shares. |
The Motley Fool
November 17, 2005
W.D. Crotty |
Dueling Fools: CNS Bear Although the consumer products maker's stock has risen 125% since 2003, it is just now reaching levels last seen in 1996. Just when investors thought they had a jackrabbit, they're reminded that this company doesn't traditionally move a mile a minute. |
The Motley Fool
November 3, 2006 |
Smell the Roses at CNS: Fool by Numbers The consumer health-care products maker released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
October 29, 2004
Rich Smith |
3 Gems for the Taking Mr. Market has already forgotten again that these companies exist, but we haven't. Here are three classic recommendations that no one on Wall Street is watching. Still high quality. Still low price. |
The Motley Fool
May 8, 2006
Rick Aristotle Munarriz |
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Let's take a closer look at four of the companies that inched their payouts higher this past week. PepsiCo... CNS... etc. |
The Motley Fool
January 24, 2006
Rich Smith |
Foolish Forecast: Simply CNS Analysts believe that CNS will grow at an annualized rate of 18% in the long term. That's tremendous, but perhaps not enough to justify its P/E ratio of 21, or its price-to-free cash flow ratio of 21. |
The Motley Fool
December 29, 2004
Rich Smith |
Panning for Gold In an equity universe with thousands of stocks to choose from, how do you sort the "good stuff" from the rubbish? Here are seven easy steps to show you how to tell a possible gem from a probable rock. |
The Motley Fool
February 3, 2006
Steven Mallas |
Coinstar: Shareholder Value in Bills? The company had a great year in terms of growth rates; margins are a different story. Investors, take note. |
The Motley Fool
October 10, 2006
Bill Mann |
Want to Find Buyout Candidates? Mergers don't always take place on great terms for shareholders, nonetheless, many investors continue to seek out these kinds of situations. It's part of the power of small-cap companies -- often they're the minnows that the big fish seek to make themselves grow. |
The Motley Fool
February 9, 2005
Rich Smith |
Hunting Baby Elephants Wouldn't you like to find -- and buy -- tomorrow's 6-ton business behemoths while they're still small? Here's how to do it. |
The Motley Fool
June 24, 2004
Nathan Parmelee |
CNS Is a Green Monster CNS packs an impressive amount of cash and, even more impressively, keeps piling up the green stuff. |
The Motley Fool
February 9, 2005
Rich Smith |
How to Turn $1,000 Into $1 Million There's no reason that it can't happen for you. Save money. Invest it regularly. Let the magic of compounding returns work for you. |
The Motley Fool
December 8, 2004
Rich Smith |
How to Turn $1,000 Into $1 Million There's no reason it can't happen for you. Save money. Invest it regularly. Let the magic of compounding returns work for you. |
The Motley Fool
October 9, 2006
Nathan Parmelee |
CNS Shareholders Can Breathe Easy CNS will be acquired by GlaxoSmithKline. There should be no bitterness on either side in this deal. CNS shareholders are getting amply rewarded. |
The Motley Fool
January 12, 2005
Rich Smith |
How to Turn $1,000 Into $1 Million There's no reason that it can't happen for you: Save money. Invest it regularly. Let the magic of compounding returns work for you. |
The Motley Fool
May 25, 2005
Rich Smith |
3 Hidden Gems for the Taking Get these stocks before they're hot on Wall Street: Radyne ComStream... Deckers... Portfolio Recovery Associates... |
The Motley Fool
January 10, 2012
Rebecca Lipman |
Earnings Surprises: The Most Underestimated Companies Reporting This Week Do you think these companies are in store for another earnings surprise? |
The Motley Fool
January 10, 2012
Alexander Crawford |
Deutsche Analyst Expects Q4 Earnings to Surprise: 10 Companies to Watch Do you think these stocks will surprise the market once more? |
The Motley Fool
August 10, 2004 |
"Diluted" vs. "Basic" Earnings The terms reflect some interesting changes in how companies report their earnings. Learn the difference so you can focus on the right numbers when investing. |
The Motley Fool
November 5, 2004
John Bluis |
Red Robin Perched Higher The restaurant beats third-quarter estimates and raises yearly guidance, but Wall Street doesn't seem to care. |
